Erythromycin and clindamycin resistance in group B streptococcal clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1875-1877

  Gygax, Scott E ^a   Schuyler, Jessica A ^a   Kimmel, Lauren E ^a   Trama, Jason P ^a   Mordechai, Eli ^a   Adelson, Martin E ^a  

^a LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION; DOUBLE DISK DIFFUSION ASSAY; ERMB GENE; ERMTR GENE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEFA GENE; MEFE GENE; MULTICENTER STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 33646464345     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1875-1877.2006     Document Type: Article

References (17)

1. Arpin, C., H. Daube, F. Tessier, and C. Quentin. 1999. Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob. Agents Chemother. 43:944-946.
2. Bozdogan, B., L. Berrezouga, M. Zuo, D. A. Yurek, K. A. Farley, B. J. Stockman, and R. Leclercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob. Agents Chemother. 43:925-929.
3. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. M100-S15, vol. 25 (no. 1). Clinical and Laboratory Standards Institute. Wayne, Pa.
4. De Azavedo, J. C. S., R. H. Yeung, D. J. Bast, C. L. Duncan, S. B. Borgia, and D. E. Low. 1999. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob. Agents Chemother. 43:2144-2147.
5. Desjardins, M., K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye. 2004. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J. Clin. Microbiol. 42:5620-5623.
6. Farrell, D. J., S. Douthwaite, I. Morrissey, S. Bakker, J. Poehlsgaard, L. Jakobsen, and D. Felmingham. 2003. Macrolide resistance by ribosomal mutations in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrob. Agents Chemother. 47:1777-1783.
7. Gibbs, R. S., S. Schrag, and A. Schuchat. 2004. Perinatal infections due to group B stretpococci. Obstet. Gynecol. 104:1062-1076.
8. Haanpera, M., P. Huovinen, and J. Jalava. 2005. Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing. Antimicrob. Agents Chemother. 49:457-460.
9. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
10. Murdoch, D. R., and L. B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother. 45:3623-3624.
11. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests; approved standard-8th ed. M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Pearlman, M. D., C. L. Pierson, and R. G. Faix. 1998. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet. Gynecol. 92:258-261.
13. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
14. Salyers, A. A., A. Gupta, and Y. Wang. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12:412-416.
15. Schrag, S. D., R. G. Gorwitz, K. Fultz-Butts, and Anne Schuchat. 2002. Prevention of perinatal group B streptococcal disease; revised guidelines from CDC. Morb. Mortal. Wkly. Rep. 51:1-22.
16. Sutclifle, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
17. Vester, B., and S. Douthwaite. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45:1-12.